Sign inJoin waitlistJoin the waitlist

VM

Vincent Miller

Medical Oncology

Credentials: · ·

History

Medical Oncology
Internal Medicine

Research

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma
Systematic review or meta-analysis · Journal of Thoracic Oncology · 2011 · 3,926 citations
EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib
Proceedings of the National Academy of Sciences of the United States of America · 2004 · 3,586 citations
Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain
Case report · PLoS Medicine · 2005 · 2,891 citations

SA
Siraj Ali
193 papers
Jeffrey Ross
183 papers
MK
Mark Kris
104 papers
JE
Julia Elvin
59 papers
William Pao
50 papers
GR
Gregory Riely
41 papers · 17 as a fellow
ML
Marc Ladanyi
32 papers
JV
Jo-Anne Vergilio
31 papers
LK
Lee Krug
31 papers
Christopher Azzoli
29 papers · 1 as a fellow
RH
Robert Heelan
29 papers
SK
Samuel Klempner
27 papers · 2 as a fellow

Grants

A Phase 2 Trial of Dasatinib in Patients with NSCLC and Acquired Resistance to Er
National Cancer Institute · R21
Contact PI · $450.6K · Sloan-Kettering Inst Can Research
2007–2010
Molecular Determinants of Acquired Erlotinib Resistance
National Cancer Institute · R21
Contact PI · $452.2K · Sloan-Kettering Inst Can Research
2005–2008

Clinical trials

Survey and Blood Sample Collection for Patients With Lung Cancer Who Never Smoked Cigarettes
Principal investigator · Completed
Memorial Sloan Kettering Cancer Center
2008–2010
Dasatinib in Treating Patients With Advanced Lung Cancer That Is No Longer Responding to Erlotinib or Gefitinib
Principal investigator · Completed · Phase 2
Memorial Sloan Kettering Cancer Center
2006–2011
Gefitinib and Everolimus in Treating Patients With Stage IIIB or Stage IV or Recurrent Non-Small Cell Lung Cancer
Principal investigator · Completed · Phase 1, Phase 2
Memorial Sloan Kettering Cancer Center
2004–2010
Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer
Study chair · Completed · Phase 1
Memorial Sloan Kettering Cancer Center
1999–2002